Constellation Brands heads into Tuesday's rescheduled print with the positioning picture notably calmer than it was ahead of last week's aborted report — but not entirely relaxed.
Options defensiveness has eased from the extremes reached in the run-up to the June 26 event. The put/call ratio now sits at 0.87, modestly above its 20-day average of 0.84 and less than one standard deviation elevated — a sharp de-escalation from the two-to-three standard deviation readings that dominated the prior week's coverage. The stock itself has recovered slightly, closing at $139.09 after a 3% weekly decline, but is essentially flat on the month. The pattern is one of residual caution rather than active hedging: investors are not paying up aggressively for downside protection the way they were heading into June 26, but neither have they fully stood down.
Short sellers have trimmed exposure since the mid-June peak. Short interest has eased to 4.35% of the free float, down about 4% on the week after briefly touching 4.7% in mid-June. The borrow market reinforces that picture — availability remains extraordinarily loose at over 2,000% and cost to borrow, while up roughly 25% over the past month, is still only 0.42%. There is no lending squeeze, no crowding, and no structural short pressure that would amplify a move in either direction.
The analyst debate has also evolved since last week. Wells Fargo cut its target to $170 the day before the rescheduled earnings, maintaining Overweight but acknowledging near-term risk. That move landed alongside TD Cowen's fresh Buy initiation at $174 and Needham's Buy reiteration at $185. The majority of targets cluster in the $168–$185 range — all comfortably above the current $139 price. BofA remains the outlier with an Underperform and a $152 target. The bull case rests on the durability of Modelo and Corona volumes, Hispanic consumer resilience, and share gains in the premium beer segment. Bears focus on FY27 guidance that disappointed in the prior print, import concentration risk, and the continued drag from non-core assets. The consensus gap — roughly 22–26% implied upside across the bullish cluster — suggests the Street believes the stock is pricing in too much bad news, but that view has been on the table for months without closing.
The report will test whether the company can deliver a beer depletion number and FY27 outlook credible enough to begin closing the gap between where the stock trades and where the bulk of the Street thinks it should.
See the live data behind this article on ORTEX.
Open STZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
